Corporate Information And Statement Of Ifrs Compliance [Abstract]

Alligator Bioscience - Filing #703045

Concept	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31
Corporate information and statement of IFRS compliance [abstract]
Name of reporting entity or other means of identification	—	Alligator Bioscience AB	—
Domicile of entity	—	Sverige	—
Legal form of entity	—	publikt aktiebolag	—
Country of incorporation	—	Sverige.	—
Address of entity's registered office	—	Medicon Village, Scheelevägen 2, 223 81 Lund	—
Principal place of business	—	Lund.	—
Description of nature of entity's operations and principal activities	—	är ett bioteknikföretag som utvecklar innovativa antikroppsbaserade läkemedel för immunterapi	—
Name of parent entity	—	Alligator Bioscience AB	—
Name of ultimate parent of group	—	Alligator Bioscience AB	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]	—	—	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current trade receivables	7 446 SEK	—	- SEK
Current trade payables	9 367 SEK	—	6 538 SEK